Introduction
============

Coenzyme Q (CoQ or ubiquinol) is a lipophilic molecule present in every cell membrane in the body ([@B13]; [@B68]). It is best known for its roles as a mitochondrial electron transporter and a potent membrane anti-oxidant ([@B20]; [@B6]). CoQ is made up of a benzoquinone ring with an isoprenoid side chain (containing 6--10 units) conserved across species from yeast (as CoQ~6~), to mice (as CoQ~7~), to humans (as CoQ~10~) ([@B35]). CoQ production in any species is the result of a complex biosynthesis process involving 10 to 15 or more genes (depending on the species) encoding a series of enzymes and non-enzymatic proteins, many of which belong to the *Coq* family of genes (*Coq 1* -- *Coq 10A/B*) ([@B1], see their Table [1](#T1){ref-type="table"} and Figure [1](#F1){ref-type="fig"} for a complete list). Despite this molecule being characterized and isolated nearly 60 years ago ([@B21]; [@B72]; [@B12]), it continues to remain relevant through ongoing investigations that are fine-tuning its roles in bioenergetics and anti-oxidant defense.

###### 

The single nucleotide polymorphisms (SNPs) in the UTR and coding area of *Coq7* gene.

  Chr   Position    Gene   dbSNP        B6   D2   function
  ----- ----------- ------ ------------ ---- ---- -----------------------
  7     118509846   Coq7   --           T    C    synonymous_variant
  7     118509921   Coq7   rs32487665   T    C    synonymous_variant
  7     118510146   Coq7   rs32487669   C    T    stop_gained
  7     118525104   Coq7   --           C    T    3_prime_utr_variant
  7     118525149   Coq7   rs32485072   T    A    3_prime_utr_variant
  7     118525163   Coq7   --           T    C    3_prime_utr_variant
  7     118525817   Coq7   rs46657874   C    G    splice_region_variant
  7     118525833   Coq7   --           G    A    synonymous_variant
  7     118525836   Coq7   --           A    G    synonymous_variant
  7     118525851   Coq7   rs13472501   A    G    synonymous_variant
  7     118529595   Coq7   rs13459101   G    A    synonymous_variant
                                                  

![Differential expression of *Coq7* across BXD RI strains rank ordered by expression level. The standard deviation and mean expression of *Coq7* in each strain is shown across the parental DBA/2J and C57BL/6J strains, F1 hybrids, and 67 BXD strains. The *x*-axis represents the mouse strain, while the *y*-axis shows the mean gene expression using the log2 scale.](fgene-09-00602-g001){#F1}

Much of the early genetic work regarding CoQ stemmed from submitochondrial fraction studies ([@B49]; [@B33]) and yeast *Saccharomyces cerevisiae* ([@B23]), which highlighted CoQ biosynthesis as necessary for mitochondrial antioxidant defense, with less CoQ production resulting in impaired defenses and increased presence of anti-oxidant molecules. But ongoing work has revealed CoQ's role as an anti-oxidant to be more complex than previously thought. *In vitro* studies using CoQ deficient skin fibroblasts showed severe (\<20% of normal) and mild (\>60%) CoQ deficiency did not increase reactive oxygen species (ROS) production while moderate deficiency (30--50%) markedly increased ROS production ([@B57], [@B56]). Recent *in vivo* studies in CoQ knockout mouse models have been more equivocal, finding that CoQ deficiency does not always directly correspond with ROS production or tissue dysfunction ([@B55]; [@B36]; [@B71]; [@B43]). This has led some researchers to emphasize the need for better characterization of CoQ's roles *in vivo* using mammalian models vs. studies *in vitro* or using yeast ([@B70]).

In the current study, we use a systems genetics approach to examine the relationship between acute ethanol effects and hippocampal *Coq7* expression in a well characterized genetic population of BXD Recombinant Inbred (RI) mice derived from the C57BL/6J (B6) and DBA/2J (D2) inbred strains, furthering our understanding of CoQ biosynthesis regulation *in vivo*. Currently, there is little evidence connecting *Coq7* and regulation of ethanol responses. However, ethanol metabolism into acetaldehyde is a well understood source of oxidative stress in the brain, causing lipid peroxidation and other oxidative damage to brain tissue ([@B25]; [@B24]). This metabolic damage is thought to be warded off by increased gene expression of endogenous anti-oxidants, such as superoxide dismutase ([@B58]; [@B19]). *Coq7* (also known as *mclk-1*) encodes a hydroxylase (coq7p) involved in one of the final steps of CoQ synthesis, conversion of demethoxyubiquinone (DMQ) to CoQ ([@B1]). This step in biosynthesis is thought to be the regulated step in CoQ biosynthesis ([@B47]; [@B53]; [@B48]; [@B38]), making it a prime target to explore how endogenous CoQ production changes in response to acute oxidative stress. Additional evidence suggesting that *Coq7* is important in alcohol responses comes from a study in HXB/BXH RI rats where *Coq7* has been proposed as a candidate gene for alcohol dependency and consumption ([@B65]).

Previous studies from our lab have shown that gene expression in the hippocampus is particularly sensitive to the effects of acute ethanol (1.8 g/kg) ([@B69]; [@B3]). Others have also shown that acute ethanol (2.0 g/kg) produces brain region-specific changes in gene expression, including in the hippocampus ([@B29]). Here, we demonstrate a positive relationship between acute ethanol ingestion and *Coq7* expression in hippocampus. We also map an expression quantitative trait locus (eQTL) for *Coq7* in BXD RI mice as well as identify pathways associated with *Coq7* and its correlated genes. Through this, we aim to better characterize *Coq7* as a vital gene in the oxidative stress response caused by brain ethanol metabolism.

Materials and Methods {#s1}
=====================

BXD Strain and Database Description
-----------------------------------

The BXD RI mouse strains were derived by crossing the parental strains B6 and D2. The F1 progeny were subsequently intercrossed followed by inbreeding to fix parental genotypes at each locus. The BXD mice are a densely phenotyped and genotyped family and have been used as a genetic reference panel for identifying the genetic basis of phenotypes and diseases, including molecular expression phenotypes, as well as for identifying pathways regulating gene expression. For this study, the dataset of Hippocampus Consortium M430v2 (Jun06) RMA that we generated previously ([@B52]) was used for genetic mapping, transcript measurement of which was taken from the hippocampus of 67 BXD strains, the parental B6 and D2 strains, and reciprocal F1 hybrids (B6D2F1 and D2B6F1). Detailed information on the strain, sex, age of each animal can be accessed from <http://genenetwork.org/webqtl/main.py?FormID=sharinginfo&GN_AccessionId=110>. This data set has been uploaded into Gene Expression Omnibus (GEO) with accession number [GSE84767](GSE84767) where the data can be downloaded.

Ethanol Treatment
-----------------

The BXD parental strains B6 and D2 mice were used for acute ethanol treatment. Ten mice per strain (2∼3 mice per sex) including both males and females at 2--4 months old were divided into two groups: (1) saline group: given an isovolumetric IP injection of saline and (2) ethanol group: treated with an IP injection of 2.0 g/kg i.p., ethanol (12.5% v/v). The dose of 2.0 g/kg of ethanol was chosen to allow for comparisons with other studies in mice seeking to produce genetically based ethanol-sensitive behaviors ([@B15]; [@B16]; [@B14]; [@B60], [@B61]). Twenty-four hours after treatment, these mice were sacrificed for tissue harvest ([@B11]).

Tissue Harvest
--------------

The B6 and D2 mice treated with ethanol or saline were anesthetized with an overdose of avertin (1.25% 2,2,2- tribromoethanol and 0.8% tert-pentyl alcohol in water; 0.8--1.0 ml, i.p.) until they were immobile, a period of less than 2 min. After this time mice were sacrificed by cervical dislocation. The hippocampi were harvested according to previously described methods ([@B39]). The left and right hippocampi were pooled and stored in RNAlater overnight at 4°C, then kept at -80°C until RNA extraction.

RNA Extraction
--------------

RNA was extracted from the hippocampus using RNA STAT-60 (protocols can be found at Tel-Test ^[1](#fn01){ref-type="fn"}^) as per the manufacturer's instructions. A spectrophotometer (Nanodrop Technologies^[2](#fn02){ref-type="fn"}^) was used to measure RNA concentration and purity, and the Agilent 2100 Bioanalyzer was used to evaluate RNA integrity. To pass quality control, the RNA integrity values needed to be greater than 8. The majority of samples had values between 8 and 10.

Gene Expression
---------------

The Affymetrix GeneChip^TM^ Mouse Transcriptome Array 1.0 (MTA 1.0) was used to generate gene expression data, from B6 and D2 mice treated with ethanol or saline, according to the manufacturers' protocol. Affymetrix Expression Console Software was used to identify and remove outlier arrays, and normalize raw data in CEL files using the Robust Multichip Array (RMA) method ([@B54]). The expression data were then re-normalized using a modified *Z* score described in a previous publication ([@B7]). We calculated the log base 2 of the normalized values, computed *Z* scores for each array, multiplied the *Z* scores by 2, and added an offset of 8 units to each value. This transformation yields a set of *Z*-like scores for each array that have a mean of 8, a variance of 4, and standard deviation of 2. The advantage of this modified *Z* score is that a twofold difference in expression corresponds approximately to a 1 unit change.

Quantitative RT-PCR
-------------------

Total RNA from 10 hippocampi per treatment group (both B6 and D2 mice) was used for a quantitative RT-PCR experiment. The gene-specific probe and primer sets for *Coq7* (upstream 5′-tttggaccatagctgcattg-3′, downstream 5′-tgaggcctcttccatactctg-3′) were deduced using Universal Probe Library Assay Design software^[3](#fn03){ref-type="fn"}^. *Coq7* mRNA levels were detected and analyzed on a LightCycler 480 System (Roche, Indianapolis, IN, Unites States^3^) under the following cycling conditions: 1 cycle at 95°C for 5 min and then 40 cycles at 95°C for 10 s, 60°C for 30 s, and 72°C for 10 s. The PCR mix contained 0.2 μl of 10 μM primers, 0.1 μl of 10 μM Universal library probe, 5 μl of LC 480 master mix (2×), 2 μl of template cDNA, and RNase-free water to 10 μl. TATA box-binding protein (TBP) was selected as the endogenous quantity control. The relative gene expression of *Coq7* was analyzed with the ΔΔCT method with TBP used as the reference gene for normalization. *Coq7* expression (fold change) in each ethanol treated mouse relative to average of the corresponding control mice was calculated as: Fold Change = 2ˆ-\[ΔCT(*Coq7* in each ethanol treated mouse) - (Mean of ΔCT of control mice)\].

Statistical Analysis
--------------------

The *Coq7* gene expression data from saline or alcohol treatment in B6 and D2 mice were evaluated using the analysis of covariance (ANCOVA) with treatment, strain, and sex as factors, and adjusted for age and body weight.

Phenotype QTL and Expression QTL (eQTL) Mapping and SNP Analysis
----------------------------------------------------------------

We performed phenotype QTL and eQTL analyses using the WebQTL module on GeneNetwork ^[4](#fn04){ref-type="fn"}^ according to our published methods ([@B9]). The genome-wide efficient mixed model association algorithm (GEMMA) was used to identify potential eQTLs regulating *Coq7* expression levels and phenotype QTLs near the *Coq7* locus, and to estimate the significance at each location using known genotypic data for those sites. Each of these analyses produced a likelihood ratio statistic (LRS) score, providing us with a quantitative measure of confidence of linkage between the observed phenotypes or expression level of *Coq7* and known genetic markers. The significance of the QTL and eQTLs were calculated using more than 2000 permutations tests. Loci were considered statistically significant if genome-wide *p* \< 0.05. Sequence variability between B6 and D2 was then determined using the Sanger mouse SNP database^[5](#fn05){ref-type="fn"}^.

Gene Function Analysis
----------------------

Prior to gene function analysis, co-expression and literature correlation were performed to filter a list of transcripts correlated with *Coq7* gene expression in the ethanol and saline groups. Co-expression analysis was performed on GeneNetwork. *Coq7* probe set expression was compared to all probe sets on the MTA 1.0 array. Criterion for significant co-expression included average log~2~ probe set expression greater than 7.0, as well as a significant correlation with *Coq7*, indicated by a Pearson product correlation value (*p* \< 0.05). We further filtered *Coq7* co-expressed probe sets in the ethanol and saline groups by performing literature correlations using the Semantic Gene Organizer to find the potential biological correlation between *Coq7* and other genes ([@B26]). Genes with higher correlation values (*r* \> 0.3) were selected for further analysis. The top 500 genes with significant co-expression (*p* \< 0.05) and literature correlations (*r* \> 0.45) for the ethanol and saline data sets were then selected and uploaded to Webgestalt^[6](#fn06){ref-type="fn"}^ for gene function analyses ([@B74]). Enrichment of biological function in the top 500 *Coq7* ethanol and saline co-expression data sets was determined using the hypergeometric test. The *p*-values from the hypergeometric test were automatically adjusted to account for multiple comparisons using the Benjamini and Hochberg correction ([@B5]). Categories with an adjusted *p*-value of less than 0.05 indicated that the set of submitted genes was significantly over-represented in those categories.

Phenotype Correlation
---------------------

We used the BXD phenotype database in our GeneNetwork website^4^ to find alcohol phenotypes highly correlated (Pearson product correlation, *p* \< 0.05) with expression of the *Coq7* probe set in hippocampus from naïve BXD mice (Hippocampus Consortium M430v2 (Jun06) RMA data set).

Results
=======

*Coq7* Expression Variance Across BXD Mice and Heritability
-----------------------------------------------------------

Only one probe set in the Affymetrix M430 dataset represents the *Coq7* gene (1415556_at), which targets the last five coding exons. *Coq7* expression (log2 scale) varied widely between BXD strains, with a fold-change of 2.57 (Figure [1](#F1){ref-type="fig"}). BXD65b had the lowest expression (9.38 ± 0.24), and BXD16 had the highest expression (10.70 ± 0.16). There is also a 1.26-fold difference in *Coq7* transcript abundance between B6 (10.15 ± 0.23) and D2 (9.81 ± 0.66).

eQTL Mapping and Sequence Variants of Coq7
------------------------------------------

The Affymetrix M430 database was used for eQTL mapping. *Coq7* is located on chromosome 7 at 118.53 Mb, and a significant eQTL modulating the expression of this gene with a likelihood ratio statistics (LRS) of 81 was mapped to the *Coq7* gene locus (Figure [2](#F2){ref-type="fig"}). This indicates that *Coq7* is *cis-*regulated, meaning one or more sequence variants affecting its expression is located within or near the gene itself. Using the open access sequence data resources at Sanger^5^, we identified 140 SNPs in *Coq7* between the BXD parental strains B6 and D2. Eleven SNPs are located at 3′-UTR and coding area (Table [1](#T1){ref-type="table"}) including one stop gain variance that could have strong downstream effect. The rest of them are located at non-coding area. All SNPs are listed in Supplementary Table [1](#SM1){ref-type="supplementary-material"}. In addition, we identified 42 indels in *Coq7* between the BXD parental strains (Supplementary Table [2](#SM2){ref-type="supplementary-material"}), with two of them being frameshift variants that could also have a strong downstream effect.

![GEMMA eQTL mapping for *Coq7* expression in hippocampus. The *x*-axis represents positions on the mouse genome in megabases (Mb), while the *y*-axis represents the likelihood ratio statistic scores (LRS), a measurement of the linkage between expression of *Coq7* and inheritance of B6 and D2 alleles at different regions of the genome. Top panel shows interval mapping for the whole mouse genome, indicating a significant eQTL at chromosome 7. Bottom panel shows a close-up view of chromosome 7 in which the peak of eQTL was around 119 Mb of chromosome 7 where *Coq7* is located (triangle).](fgene-09-00602-g002){#F2}

Expression Differences of *Coq7* Between Saline and Ethanol Groups
------------------------------------------------------------------

We used the Affymetrix MTA datasets to analyze the effect of alcohol on the expression of *Coq7* in the hippocampal tissue of B6 and D2 mice using an ANOVA with treatment, strain and sex as the between subject factors. The average of *Coq7* expression in the saline group was 7.46 ± 0.01 (log2 scale), while the average for the ethanol group was 7.52 ± 0.01 (log2 scale), indicating an increase in expression after ethanol treatment. ANCOVA analysis showed a significant effect of ethanol treatment on *Coq7* transcript abundance (*P* = 0.029) and also interaction of ethanol treatment and sex significantly effects on *Coq7* transcript abundance (*P* = 0.002) (Table [2](#T2){ref-type="table"}). For B6 strain, the average of Coq7 expression in the ethanol group was 7.53 ± 0.04 (log2 scale), while the average for the saline group was 7.46 ± 0.03 (log2 scale). For D2 strain, the average of Coq7 expression in the ethanol group was 7.51 ± 0.05 (log2 scale), while the average for the saline group was 7.47 ± 0.03 (log2 scale). The *T*-test analysis showed a significant effect of ethanol treatment on *Coq7* transcript abundance in the B6 strain (*P* = 0.0234), not in the D2 strain (*P* = 0.2454).

###### 

ANOVA analysis of *Coq7* expression in the hippocampus.

  Source               df   Sums of Squares   Mean Square   *F*-ratio   *P*-value
  -------------------- ---- ----------------- ------------- ----------- -----------
  Intercept            1    1123.54           1123.54       3839480     \<0.0001
  Treatment            1    0.003281          0.003281      11.213        0.0286
  Strain               1    0.000225          0.000225      0.7684        0.4302
  Treatment^∗^Strain   1    0.001315          0.001315      4.4951        0.1013
  Sex                  1    0.000281          0.000281      0.9592        0.3828
  Treatment^∗^sex      1    0.013775          0.013775      47.073        0.0024
  Strain^∗^Sex         1    0.000037          0.000037      0.12496       0.7416
  Age                  1    0.000455          0.000455      1.5543        0.2805
  Treatment^∗^Age      1    0.001535          0.001535      5.2472        0.0838
  Strain^∗^Age         1    0.001828          0.001828      6.2477        0.0668
  Sex^∗^Age            1    0.001784          0.001784      6.097         0.069
  Body Weight (Wt)     1    0.002022          0.002022      6.9113        0.0583
  Treatment^∗^BodyWt   1    0.000328          0.000328      1.1205        0.3495
  Strain^∗^BodyWt      1    0.000149          0.000149      0.50948       0.5148
  Sex^∗^BodyWt         1    0.000631          0.000631      2.1555        0.216
  Age^∗^BodyWt         1    0.001043          0.001043      3.5626        0.1321
  Error                4    0.001171          0.000293                  
  Total                19   0.039494                                    
                                                                        

qRT-PCR Validation
------------------

*Coq7* expression was validated using RT-PCR. The RT-PCR results showed significantly increased expression of *Coq7* (*F* = 11.77, *P* = 0.027) after ethanol treatment. This was consistent with the results from microarray analysis. In addition, we also found significant strain differences between B6 and D2 (*F* = 9.326, *P* = 0.038), and sex difference between males and females (*F* = 11.788, *P* = 0.027).

Gene Ontology Analysis
----------------------

We used the top 500 transcripts co-expressed with *Coq7* from both saline and ethanol group to perform gene ontology (GO) analysis. For the saline-treated group, significant biological processes included "ATP metabolic process," "mitochondrion organization," "electron transport chain," and "ubiquinone biosynthetic process" (Supplementary Table [3](#SM3){ref-type="supplementary-material"}). For the ethanol treated group, 54 enriched GO biological processes categories reached significance (Supplementary Table [4](#SM4){ref-type="supplementary-material"}). Many of the categories in the ethanol group overlapped with those in the saline group, but all of the ATP metabolic and mitochondrial function related categories were no longer significant. Instead, several new enriched categories including serine metabolic process, behavior and cognition show up.

Gene pathway enrichment analysis for the saline-treated group revealed 21 related pathways (adj *P* \< 0.05, Table [3](#T3){ref-type="table"}), while the ethanol-treated group revealed six related pathways (adj *P* \< 0.05, Table [4](#T4){ref-type="table"}). The top enriched pathway in the saline group including "Electron Transport Chain" and "Oxidative phosphorylation" are not shared with the ethanol group. A pathway of interest unique to the ethanol group is "Oxidative stress."

###### 

Significant pathways for the Saline group.

  Pathway name                                 \# of genes   raw *P*-value   adj *P*-value
  -------------------------------------------- ------------- --------------- ---------------
  Electron Transport Chain                     24            1.29E-19        6.97E-18
  TCA Cycle                                    13            1.61E-14        4.35E-13
  Amino Acid metabolism                        19            8.53E-13        1.54E-11
  Oxidative phosphorylation                    13            9.11E-11        1.23E-09
  Glycolysis and Gluconeogenesis               12            1.22E-10        1.32E-09
  Kennedy pathway                              6             1.58E-07        1.42E-06
  Fatty Acid Biosynthesis                      6             1.94E-05        0.0001
  One carbon metabolism and related pathways   6             0.0004          0.0027
  PPAR signaling pathway                       8             0.0005          0.003
  Nucleotide Metabolism                        4             0.0006          0.0032
  One Carbon Metabolism                        5             0.001           0.0042
  Folic Acid Network                           4             0.0009          0.0042
  Proteasome Degradation                       6             0.0011          0.0042
  selenium                                     4             0.001           0.0042
  Glutathione and one carbon metabolism        4             0.0045          0.0159
  mRNA processing                              18            0.0047          0.0159
  Acetylcholine Synthesis                      2             0.0078          0.0248
  Urea cycle and metabolism of amino groups    3             0.0091          0.0273
  Triacylglyceride Synthesis                   3             0.0103          0.0293
  Glutathione metabolism                       3             0.0116          0.0313
                                                                             

###### 

Significant pathways for the Ethanol group.

  Pathway name                                     \# of genes   raw *P*-value   adj *P*-value
  ------------------------------------------------ ------------- --------------- ---------------
  One carbon metabolism and related pathways       7             4.62E-05        0.0027
  mRNA processing                                  20            0.0008          0.0155
  Cytoplasmic Ribosomal Proteins                   7             0.0008          0.0155
  Oxidative Stress                                 4             0.0021          0.0305
  Glutathione and one carbon metabolism            4             0.0043          0.0416
  Myometrial Relaxation and Contraction Pathways   9             0.0042          0.0416
                                                                                 

Phenotype Correlation Analysis
------------------------------

We performed correlational analyses with phenotypes archived in the GeneNetwork database to identify ethanol-related behaviors correlated with *Coq7* (*p* \< 0.05) expression in the hippocampus. We found 45 ethanol-related phenotypes significantly correlated with *Coq7* expression (Supplementary Table [5](#SM5){ref-type="supplementary-material"}), most of which are related to ethanol consumption, ethanol response, ethanol preference, and body temperature after ethanol treatment; some of which are mapped near *Coq7* location. For example, one phenotype (record ID 10496, ethanol response) has a significant QTL with a LRS of 13.8 (*P* \< 0.05) on chromosome 7 at 114∼119 Mb (Figure [3](#F3){ref-type="fig"}) where *Coq7* is located.

![GEMMA QTL mapping for locomotion behavior after ethanol injection (2 g/kg). The *x*-axis represents a position on the mouse genome in megabases (Mb), while the y-axis gives the likelihood ratio statistic scores (LRS). The mapping result showed that the peak of QTL was around 114∼119 Mb of chromosome 7.](fgene-09-00602-g003){#F3}

Discussion
==========

Currently, mechanisms through which ethanol affects *Coq7* and ubiquinone are unknown and previous studies analyzing *Coq7* and ethanol are lacking. To this end, we attempted to elucidate the relationship between ethanol and expression of *Coq7* in the hippocampus of BXD mice by identifying genes and biological pathways that may link the two. *Coq7* is variably expressed in naïve hippocampal tissue from BXD RI strains and is *cis-*regulated, making it an excellent candidate for study as a modifier of gene expression or biological phenotypes ([@B10]). We found that there are multiple SNPs and Indels in *Coq7*, which may be responsible for its differential expression in the hippocampal tissues across BXD strains. This also suggests that one or more polymorphism may affect *Coq7* expression and play a role in gene regulation ([@B32]; [@B27]). Furthermore, we found increased expression of *Coq7* following acute ethanol injection and identified 45 ethanol-related phenotypes correlated with *Coq7*, supporting its likely involvement in ethanol responses (Supplementary Table [5](#SM5){ref-type="supplementary-material"}). These findings included six phenotypes related to conditioned taste aversion and ethanol preference. It has been previously proposed that *Coq7* may play a role in alcohol consumption ([@B65]), aligning with the result of our phenotypic analysis. While this phenotypic alignment is interesting, it should be noted that our experiment did not directly test ethanol consumption behaviors before and after ethanol injection, limiting how generalizable this result may be. Future direct observation of changes in ethanol preferences following ethanol injection or a period of oral consumption would likely be worthwhile.

Comparison of functional enrichment analysis results between our treatment groups may hold insight into why *Coq7* was upregulated following ethanol injection. In the saline treatment group, we found processes related to cellular metabolism and ATP generation (Supplementary Table [3](#SM3){ref-type="supplementary-material"}). Presumably, when proteins needed to break down energy substrates are expressed, *Coq7* is also expressed. This is unsurprising considering CoQ's role in the electron transport chain as an electron shuttle, representing a lynchpin of the final step of ATP generation following metabolism. Conversely, these metabolic functions were largely insignificant in the ethanol treatment group's analysis, suggesting a less prominent role. This may well be representative of ethanol's effect on the mitochondria, which has been shown to decrease respiratory rates and the rate of ATP synthesis following chronic exposure ([@B66]; [@B46]). This notion was further corroborated by pathway enrichment analysis, which found pathways such "Electron Transport Chain," "TCA cycle," "Amino Acid Cycle," "Oxidative phosphorylation," and "Glycolysis and Gluconeogenesis" associated with the saline treated group (Table [3](#T3){ref-type="table"}), but not the ethanol treatment group.

The ethanol group uniquely had "Oxidative Stress" as a significantly enriched gene pathway (Table [4](#T4){ref-type="table"}). Notably, three of the four genes in this gene pathway encode proteins contributing to anti-oxidant enzymes: *Sod2* (superoxide dismutase, [@B2]), *Gclc* (glutamate-cysteine ligase, a catalyst for glutathione synthesis; [@B40], [@B41]), and *Txnrd1* (thioredoxin reductase 1; [@B67]). While all three are well-established anti-oxidants, previous work on their interactions with ethanol vary greatly. Superoxide dismutase (SOD) is perhaps best studied but also the most controversial. SOD activity in the murine brain following ethanol exposure has been shown to increase ([@B64]; [@B19]; [@B59]), remain unchanged ([@B22]) and decrease ([@B34]) under various conditions. The other two genes are less well characterized. *Gclc* mRNA expression shown to be induced by ethanol in rat liver and brain ([@B42]; [@B50]) and *Txnrd1* has not been as well studied in terms of ethanol-induced stress.

However, a recent paper by [@B8] found all three of these genes, as well as many other anti-oxidant genes, to have increased expression in hippocampal derived HT22 cells following acute, sub-toxic ethanol exposure. To explain its result, this paper emphasized the growing understanding of ROS as second messengers, capable of influencing gene expression ([@B18]; [@B28]; [@B62]). These findings have been pioneered in the growing field of "redox biology," which heavily emphasizes a more nuanced understanding of the impact of ROS. Current work suggests that varying levels of ROS production (so called "basal," "low," "intermediate," and "high" oxidative stress) cause different cellular reactions ([@B44]; [@B63]). [@B8] reasoned that low levels of ethanol increased the level of oxidative stress, as ethanol is a well-documented potent producer of ROS by virtue of its metabolism ([@B37]; [@B73]; [@B17]), resulting in beneficial mitohormetic anti-oxidant gene expression.

This phenomenon may similarly be occurring in our study, as evidenced by the induction of *Coq7* and the phenotypic shift to oxidative stress protection in the ethanol treatment group. It may be that CoQ is unimportant as an anti-oxidant under basal or low-level oxidative stress, as seen in CoQ knockout mouse studies, but is induced under heightened oxidative stress levels alongside other well-known anti-oxidants. The variation of *Coq7* expression in BXD RI mice could result in variation in this inducible response, accounting for differences in how individual strains of BXDs react to ethanol ingestion. [@B65] argue that several of their identified "alcohol consumption genes" could theoretically modulate GABA release from the hypothalamus to areas like the ventral tegmental area, ultimately affecting downstream reward behaviors through a variety of molecular mechanisms (see their Figure [3](#F3){ref-type="fig"}). Logically, the variation in genetic expression among individuals or under different conditions may end up modulating behavior. While Tabakoff mentions *Coq7* as an identified "ethanol consumption gene," they do not outline how it might affect GABA release in this way. With the idea of ROS as signaling molecules in mind, variation in *Coq7* expression (or other anti-oxidant defenses) could limit or permit ROS signaling, potentially altering critical neurologic signaling pathways related to reward-seeking behavior, similar to those proposed by [@B65]. How these alterations would occur is still a matter of investigation. Work has examined some of the intracellular mechanisms by which ROS can affect plasticity and signaling in the hippocampus, mainly through induction of long-term potentiation (LTP). This induction seems to be through ROS acting as a second messenger, inducing phosphorylation of established LTP effectors such as PKC, ERK, and CamKII ([@B45]; [@B31]; [@B30]). For recent reviews on the topic, please see [@B4] and [@B51]. However, there has been little investigation into ROS's effect on motivational circuitry. While further work is needed, ethanol-induced oxidative stress may represent a worthwhile line of inquiry to better understand hippopcampal cellular responses to heightened oxidative stress *in vivo* and their downstream effects on neurotransmission and behavior.

In sum, we analyzed the effect of ethanol on the expression of *Coq7* using a systems genetic approach. We identified an eQTL showing variability in *Coq7* expression in BXD RI mice and found its expression to be increased following ethanol treatment. We also uncovered several pathways and genes which may interact with *Coq7* to regulate the ethanol response. Based on this and previous reports, *Coq7* may act as an inducible anti-oxidant at heightened levels of oxidative stress, aligning both with previous work and current questions on this ubiquitous molecule. Further research into the specific interactions between *Coq7* and identified genes may elucidate their relationships and shed light on how *Coq7* affects mitochondria following acute ethanol consumption.
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